Monte Rosa Therapeutics had a revenue of 2.78M in the quarter ending Dec 31, 2025, with -78.22%. This bring the company's revenue in the last twelve months to 123.67M, Increased -31.88%. In the fiscal year ending Dec 31, 2025, Monte Rosa Therapeutics had annual revenue of 123.67M with 63.54% growth.